In Response to "Comment on Ensuring the Efficacy and Safety of Approved Medications".

Mazer-Amirshahi, Maryann; Cole, Jon B; Stolbach, Andrew I; Perrone, Jeanmarie; Nelson, Lewis S

Mazer-Amirshahi, Maryann; Cole, Jon B; Stolbach, Andrew I; Perrone, Jeanmarie; Nelson, Lewis S.

Afiliación

Mazer-Amirshahi M; Department of Emergency Medicine, MedStar Washington Hospital Center, Georgetown University School of Medicine, National Capital Poison Center, Washington, DC, USA. maryannmazer@gmail.com.
Cole JB; Department of Emergency Medicine, Minnesota Poison Control System, Hennepin Healthcare, University of Minnesota Medical School, Minneapolis, MN, USA.
Stolbach AI; Department of Emergency Medicine, John Hopkins School of Medicine, Baltimore, MD, USA.
Perrone J; Department of Emergency Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Nelson LS; Department of Emergency Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.

J Med Toxicol ; 20(3): 332-333, 2024 Sep.

Article en En | MEDLINE | ID: mdl-38702539

Asunto(s)

Aprobación de Drogas; Humanos; United States Food and Drug Administration; Estados Unidos; Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/prevención & control

Palabras clave

Efficacy; Intranasal epinephrine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aprobación de Drogas Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Med Toxicol Asunto de la revista: TOXICOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google